Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension

Abstract Background Pulmonary hypertension (PH) confers increased mortality in patients with chronic lung disease, yet there remains a lack of validated risk assessment tools to prognosticate these patients. We aimed to create a risk assessment tool to stratify patients with chronic lung disease and...

Full description

Saved in:
Bibliographic Details
Main Authors: Shameek Gayen, Jay Pescatore, Matthew Bittner, Mario Naranjo, Gerard J. Criner, Sheila Weaver, Temple Lung Center Pulmonary Vascular Disease Working Group
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Pulmonary Medicine
Subjects:
Chronic lung disease
Pulmonary hypertension
Pulmonary fibrosis
Pulmonary vascular resistance
BNP
Mortality
Online Access:https://doi.org/10.1186/s12890-025-03538-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12890-025-03538-8

Similar Items